[PDF][PDF] VPS35 mutations in Parkinson disease

…, JO Aasly, PR Burkhard, R Djaldetti… - The American Journal of …, 2011 - cell.com
The identification of genetic causes for Mendelian disorders has been based on the collection
of multi-incident families, linkage analysis, and sequencing of genes in candidate intervals…

[HTML][HTML] The natural history of multiple system atrophy: a prospective European cohort study

…, R Dodel, C Sampaio, M Coelho, R Djaldetti… - The lancet …, 2013 - thelancet.com
Background Multiple system atrophy (MSA) is a fatal and still poorly understood degenerative
movement disorder that is characterised by autonomic failure, cerebellar ataxia, and …

Bax ablation prevents dopaminergic neurodegeneration in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine mouse model of Parkinson's disease

…, S Vukosavic, R Djaldetti… - Proceedings of the …, 2001 - National Acad Sciences
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) damages dopaminergic neurons in the
substantia nigra pars compacta (SNpc) as seen in Parkinson's disease. Here, we show that …

The mystery of motor asymmetry in Parkinson's disease

R Djaldetti, I Ziv, E Melamed - The Lancet Neurology, 2006 - thelancet.com
The motor symptoms of Parkinson's disease are predominantly due to progressive
degeneration of nigral dopaminergic neurons. In most cases there is a substantial asymmetry of …

The parkinsonian toxin MPTP: action and mechanism

…, V Jackson-Lewis, R Djaldetti… - Restorative …, 2000 - content.iospress.com
MPTP causes damage to substantia nigra pars compacta (SNpc) dopaminergic (DA) neurons
as seen in Parkinsons disease (PD). After sys-temic administration of MPTP, its active …

Increased plasma endothelin-1 in acute ischemic stroke.

I Ziv, G Fleminger, R Djaldetti, A Achiron, E Melamed… - Stroke, 1992 - Am Heart Assoc
Endothelins are a recently discovered group of most powerful vasoconstrictor peptides.
Endothelin-1 is produced by endothelial cells, and endothelin-3 is derived from neuronal tissue. …

Presentation, diagnosis, and management of multiple system atrophy in Europe: final analysis of the European multiple system atrophy registry

…, MT Pellecchia, P Barone, R Djaldetti… - Movement …, 2010 - Wiley Online Library
Multiple system atrophy (MSA) is a Parkinson's Disease (PD)‐like α‐synucleinopathy clinically
characterized by dysautonomia, parkinsonism, cerebellar ataxia, and pyramidal signs in …

Red flags for multiple system atrophy

…, C Kamm, T Gasser, R Djaldetti… - … : official journal of the …, 2008 - Wiley Online Library
The clinical diagnosis of multiple system atrophy (MSA) is fraught with difficulty and there
are no pathognomonic features to discriminate the parkinsonian variant (MSA‐P) from …

Camptocormia (bent spine) in patients with Parkinson's disease—characterization and possible pathogenesis of an unusual phenomenon

R Djaldetti, R Mosberg‐Galili, H Sroka… - … : official journal of the …, 1999 - Wiley Online Library
Camptocormia is characterized by severe forward flexion of the thoracolumbar spine which
increases while walking and disappears in the recumbent position. We describe for the first …

Cannabis (medical marijuana) treatment for motor and non–motor symptoms of Parkinson disease: An open-label observational study

…, TA Treves, Y Roditi, R Djaldetti - Clinical …, 2014 - journals.lww.com
Objective The use of cannabis as a therapeutic agent for various medical conditions has
been well documented. However, clinical trials in patients with Parkinson disease (PD) have …